The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Cortiment 9 mg prolonged release tablets



Ferring Ireland LtdPA1009/026/001

Main Information

Trade NameCortiment 9 mg prolonged release tablets
Active SubstancesBudesonide
Dosage FormProlonged-release tablet
Licence HolderFerring Ireland Ltd
Licence NumberPA1009/026/001

Group Information

ATC CodeA07EA Corticosteroids acting locally
A07EA06 budesonide

Status

License statusAuthorised
Licence Issued05/12/2014
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back